PET-CT Scan: Cancer Imaging, Preparation, and Result Interpretation

A PET-CT scan combines metabolic and anatomical imaging to help doctors detect, stage, and monitor many types of cancer. Understanding the preparation, scan process, and result interpretation can help patients feel more confident and informed.

Overview: What Is a PET-CT Scan?

A PET-CT scan is an advanced imaging test that combines two technologies in one examination. PET stands for positron emission tomography, which shows how active cells and tissues are. CT stands for computed tomography, which uses X-rays to create detailed cross-sectional pictures of the body. When these images are combined, doctors can see both where an abnormal area is located and how it is functioning.

The most common PET tracer used in cancer imaging is fluorodeoxyglucose, often called FDG. FDG is a radioactive form of glucose, or sugar. Many cancer cells use more glucose than normal cells, so they may appear as areas of increased activity on the PET image. The CT portion helps identify the exact location of these active areas, such as in a lymph node, lung, bone, or organ.

PET-CT is widely used in oncology because cancer is not only a structural disease but also a biological one. A mass may look similar on a standard scan, yet its metabolic activity can provide important additional information. PET-CT can also image much of the body in one session, which is useful when doctors need a broad view for cancer staging or follow-up.

When PET-CT Is Used in Cancer Care

PET-CT is not needed for every cancer or every patient, but it can be very helpful in selected situations. Doctors may request it when they need to determine whether cancer has spread, evaluate unclear findings on other scans, or assess whether treatment is working. It may also be used after treatment to look for signs of recurrence when symptoms, blood tests, or other imaging results raise a question.

In cancer care, PET-CT may be used for several purposes:

• Staging cancer before treatment begins, especially when spread to lymph nodes or distant organs is possible.
• Checking response to chemotherapy, immunotherapy, radiotherapy, or targeted therapies.
• Distinguishing active tumor tissue from scar tissue after treatment.
• Helping doctors choose the best site for biopsy when several abnormal areas are present.
• Assisting in radiotherapy planning in certain cancers.

PET-CT is commonly used in lymphoma, lung cancer, colorectal cancer, melanoma, head and neck cancers, esophageal cancer, and some gynecologic cancers, among others. However, its value depends on cancer type, tumor biology, stage, and the clinical question being asked. The referring doctor and imaging specialist decide whether PET-CT is appropriate for the individual situation.

How a PET-CT Scan Works

Before the scan, a small amount of radioactive tracer is injected into a vein, usually in the arm. The tracer travels through the bloodstream and is taken up by tissues. After an uptake period, commonly about an hour, the patient lies on a scanning table that moves slowly through the PET-CT machine. The scan itself is painless, and the patient is usually asked to remain still so the images are clear.

The PET camera detects signals from the tracer and creates images showing areas of increased or decreased metabolic activity. The CT scan provides the anatomical map. In some cases, CT is performed without contrast and is mainly used for image matching and correction. In other cases, a diagnostic CT with intravenous or oral contrast may be added if more detailed anatomical information is needed.

The amount of radioactivity used is controlled and kept as low as reasonably possible while still producing useful images. The tracer loses radioactivity over time and leaves the body mainly through urine. Patients are often advised to drink fluids after the scan unless their doctor has restricted fluid intake for another medical reason.

PET-CT Preparation: Food, Medicines, and Safety

Preparation is important because high blood sugar or recent muscle activity can affect FDG uptake and image quality. Most patients are asked to fast for several hours before the scan, usually with water allowed. They may also be advised to avoid strenuous exercise for about 24 hours beforehand, because active muscles can take up more tracer and make interpretation more difficult.

Patients should tell the imaging team about diabetes, pregnancy, breastfeeding, kidney disease, allergies to contrast material, recent infections, recent surgery, and current medicines. People with diabetes may need individualized instructions about meals, insulin, or diabetes tablets to keep blood glucose within a suitable range for the scan. Medicines should not be stopped unless the treating doctor or imaging team specifically advises it.

On the day of the scan, comfortable clothing without metal parts is helpful. Jewelry, belts, or removable metal objects may need to be taken off. During the uptake period after the tracer injection, patients are usually asked to rest quietly, stay warm, and avoid talking or moving too much. This helps reduce unnecessary tracer uptake in muscles.

Patients who are pregnant or may be pregnant should inform the medical team before the scan. PET-CT may be postponed or replaced with another imaging test depending on the clinical need. Breastfeeding patients should also ask for specific instructions, as temporary precautions may be recommended after tracer injection.

What to Expect During and After the Scan

A PET-CT appointment often takes two to three hours in total, although the actual scanning time is usually much shorter. After registration and safety checks, the tracer is injected. The patient then rests during the uptake period. When it is time for imaging, the patient lies on a narrow table that moves through a ring-shaped scanner. The machine does not usually enclose the whole body in the same way as some MRI scanners.

The scan is painless, but lying still may feel uncomfortable for some people. The technologist can communicate with the patient during the procedure. If contrast material is used for the CT portion, a warm sensation, metallic taste, or brief flushing can occur; these effects usually pass quickly. Patients with previous contrast reactions should tell the team before the scan begins.

After the scan, most people can return to normal activities unless they were given different instructions. Drinking water and emptying the bladder regularly can help clear the tracer from the body. The imaging team may advise limiting close contact with pregnant people or very young children for a short time, depending on local protocols and the tracer used.

Understanding PET-CT Results

PET-CT results are interpreted by trained specialists, often nuclear medicine physicians and radiologists. The report describes areas of tracer uptake, their location on CT images, and whether the pattern is suspicious, likely benign, or requires further evaluation. The report may mention standardized uptake value, or SUV, which is a measurement of tracer concentration in a region. SUV can be useful, but it is not a diagnosis by itself.

Increased FDG uptake can be seen in many cancers, but it can also occur with infection, inflammation, healing after surgery, recent radiation effects, arthritis, and normal organs such as the brain, heart, kidneys, and bladder. Some slow-growing or small tumors may show low uptake and can be harder to detect. For this reason, PET-CT findings must be interpreted together with symptoms, physical examination, laboratory tests, biopsy results, and previous imaging.

A PET-CT report may use terms such as complete metabolic response, partial metabolic response, stable disease, or progression when assessing treatment response. These terms help oncologists compare scans over time and plan the next steps. Patients should review the results with their treating doctor, who can explain what the findings mean for their specific cancer type and treatment plan.

Benefits, Limitations, and When to Speak With a Doctor

The main benefit of PET-CT is that it provides both functional and anatomical information in one test. It can detect active disease that may not be obvious on structural imaging alone, and it can help avoid unnecessary procedures when findings are clearly explained in the context of the patient’s overall condition. It is especially useful when doctors need to compare disease activity before, during, or after treatment.

Like all medical tests, PET-CT has limitations. It involves exposure to radiation, although the test is ordered when the expected medical benefit outweighs this risk. It may not detect very small lesions or cancers that do not take up much FDG. It may also show uptake from non-cancer causes, which can lead to additional tests such as follow-up imaging or biopsy.

Patients should contact their doctor or imaging center before the appointment if they are pregnant, breastfeeding, have diabetes, have had a recent infection or surgery, or have a known contrast allergy. They should also ask when and how results will be available. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can support international patients with PET-CT diagnosis and cancer care planning when clinically appropriate.

Frequently asked questions

Is a PET-CT scan painful?

The scan itself is not painful. Patients may feel a small needle prick when the tracer is injected into a vein. The main challenge for some people is lying still during the imaging portion.

How long does a PET-CT scan take?

The full appointment often takes two to three hours because there is a waiting period after the tracer injection. The scan itself is usually much shorter. Timing can vary depending on the body area studied and whether contrast-enhanced CT is performed.

Can PET-CT tell for certain whether something is cancer?

PET-CT can show areas of increased metabolic activity that may be suspicious for cancer, but it does not always provide a final diagnosis on its own. In some cases, inflammation or infection can look active on PET. A biopsy or additional tests may be needed to confirm the diagnosis.

Why is fasting needed before a PET-CT scan?

Fasting helps keep blood sugar and insulin levels stable so the FDG tracer is distributed more accurately. If blood sugar is high, image quality may be reduced and some findings may be harder to interpret. Patients with diabetes should receive individualized instructions from the imaging team.

Is the radiation from PET-CT dangerous?

PET-CT uses a controlled amount of radiation from both the tracer and the CT scan. Doctors recommend it when the expected benefit for diagnosis or treatment planning is greater than the potential risk. Patients who are pregnant or may be pregnant should always inform the medical team before the scan.

What does SUV mean on a PET-CT report?

SUV, or standardized uptake value, is a measure of how much tracer is present in a specific area. Higher SUV can suggest increased metabolic activity, but it is not the same as a cancer diagnosis. Doctors interpret SUV together with the appearance, location, medical history, and previous scans.

References

• World Health Organization
• International Atomic Energy Agency
• Society of Nuclear Medicine and Molecular Imaging
• European Association of Nuclear Medicine
• National Cancer Institute

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.